TABLE 2.
Tumor types | Clinicopathological features | Ref |
---|---|---|
GC | poor tumor differentiation, more lymph node metastasis, vascular invasion, high AJCC stage, poor OS and DFS | Cai and Zuo, (2019) |
GBM | advanced histological grade, more blood vascular microvessel density, poor OS and PFS | (Barbagallo et al., 2018; Barbagallo et al., 2019) |
HCC | poor tumor differentiation, high TNM stage, microvascular invasion, large tumor size and more tumor lesions | (Yu et al., 2018; Zhang et al., 2018; Li ad Hu, 2019) |
NSCLC | large tumor size, more lymphatic metastasis and high TNM stage | (Tong, 2020; Zhang et al., 2020) |
ICC | ECOG performance score, advanced TNM stage and abnormal CA199 status | Lu, (2020) |
MM | high beta-2-microglobulin levels, poor complete response and short OS and PFS after effective chemotherapy | Liu et al. (2019) |
BCa | larger tumor size, higher tumor stage, lymphatic metastasis and worse DFS and OS | (Tan and Liang. 2019; Zhang X et al., 2021) |
Abbreviations: GC: gastric cancer; GBM: glioblastoma; HCC: hepatocellular carcinoma; NSCLC: non-small -cell lung cancer; ICC: intrahepatic cholangiocarcinoma; MM: multiple myeloma; BCa: bladder cancer.